Beyond half-life extension: characterising how rFVIIIFc impacts the immune system

FRIDAY, 15th September
15.30 – 16.30

Stefan Lethagen, Sobi™, Sweden
Stephen James, Sobi™, Sweden

15.30 – 15.40 Welcome & Introduction
Stefan Lethagen, Sobi™, Sweden
15.40 – 15.50 Retrospective real world analysis of haemophilia A patients with inhibitors treated with rFVIIIFc for immune tolerance induction
Jennifer Dumont, Bioverativ™, USA
15.50 – 16.05 Elucidating rFVIIIFc interactions with the immune system
Katalin Kis-Toth, Bioverativ™ USA
16.05 – 16.20 MHC class II presentation of Fc Tregitope and FVIII epitopes in rFVIIIFc: Potential implications for tolerance
Margareta Wikén, Sobi™, Sweden
16.20 – 16.30 Q&A Session and closing remarks
Stephen James, Sobi™, Sweden